Mouse Models of Prostate Cancer
Open Access
- 23 February 2011
- journal article
- review article
- Published by Hindawi Limited in Prostate Cancer
- Vol. 2011, 1-22
- https://doi.org/10.1155/2011/895238
Abstract
The development and optimization of high-throughput screening methods has identified a multitude of genetic changes associated with human disease. The use of immunodeficient and genetically engineered mouse models that mimic the human disease has been crucial in validating the importance of these genetic pathways in prostate cancer. These models provide a platform for finding novel therapies to treat human patients afflicted with prostate cancer as well as those who have debilitating bone metastases. In this paper, we focus on the historical development and phenotypic descriptions of mouse models used to study prostate cancer. We also comment on how closely each model recapitulates human prostate cancer.Keywords
This publication has 199 references indexed in Scilit:
- Production of p53 gene knockout rats by homologous recombination in embryonic stem cellsNature, 2010
- Molecular characterization of the Gγ‐globin‐Tag transgenic mouse model of hormone refractory prostate cancer: Comparison to human prostate cancerThe Prostate, 2010
- Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse modelThe Prostate, 2009
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostateNature Genetics, 2009
- Efficient tumour formation by single human melanoma cellsNature, 2008
- Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancerDifferentiation, 2008
- Prostate stem cells and benign prostatic hyperplasiaThe Prostate, 2008
- The current state of preclinical prostate cancer animal modelsThe Prostate, 2008
- Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancersNature, 2007
- The Hallmarks of CancerCell, 2000